Regulatory Submission Success Rate KPI

Regulatory Submission Success Rate is a critical performance indicator that reflects how effectively an organization navigates compliance requirements.

High success rates can lead to faster market access, reduced costs associated with resubmissions, and improved stakeholder confidence.

Conversely, low rates may indicate inefficiencies in operational processes or inadequate preparation.

Organizations that excel in this KPI often enjoy enhanced financial health and better strategic alignment with regulatory bodies.

By leveraging data-driven decision-making, firms can track results and improve their submission processes significantly.

How Regulatory Submission Success Rate Connects to Your Strategy

Regulatory Submission Success Rate belongs to a single KPI group, Medical Devices & Diagnostics, and it sits near the front of it at priority 3 of 62 members. Only Time-to-Regulatory Approval and Regulatory Compliance Rate rank ahead of it, and it leads the Regulatory Audit Findings and Regulatory Inspection Readiness that follow. This is a lead compliance metric, not a supporting one.

Its BSC placement is the internal-process perspective. In a regulated device business that makes it a leading indicator of downstream outcomes: the quality of what a team submits predicts how fast approval comes and how clean the next audit is, well before those results land.

The defining tension is with Time-to-Regulatory Approval at priority 1. Compressing approval time is the group's headline goal, but rushing dossiers out the door is the fastest way to draw requests for additional information, which is exactly what drops the submission success rate. The two metrics have to move together or they trade against each other: a team that optimizes purely for speed will submit more, fail more on first pass, and quietly lengthen the very timeline it was trying to shorten.

Measuring Regulatory Submission Success Rate in Practice

The metric is successful submissions over total submissions. The source data lives in the regulatory information management system and the submission tracking log, where each submission carries a type, a target authority, and an outcome. Join outcomes back to the submission on its own identifier, and decide up front whether a submission is dated by when it was filed or by when the decision returned, because the two produce different period rates.

Definitional forks to resolve before measuring:

• What successful means. Approved with no request for additional information or modification, as the definition states, versus eventually approved after rework. The first is a first-pass quality measure; the second is far more forgiving and tells a different story.
• Whether resubmissions re-enter the denominator. If a corrected refiling counts as a fresh submission, a team can dilute its failure rate by splitting and resubmitting.
• Which submission types are in scope. Pre-market applications, supplements, and change notifications carry different difficulty, so mixing them without a breakdown blurs the signal.

Segment by submission type, product class, and regulatory authority, since a strong domestic first-pass rate can hide repeated deficiencies with a specific regulator. Watch small denominators: with a handful of high-stakes submissions in a period, one outcome swings the rate hard, so report the count alongside the rate and avoid over-reading short windows.

Common Pitfalls

Many organizations underestimate the complexity of regulatory submissions, leading to avoidable errors and delays.

• Relying on outdated templates can result in missed requirements. Regulatory guidelines frequently change, and failing to update submission formats may lead to rejections or delays.
• Inadequate training for staff on compliance standards can create inconsistencies. Employees may not fully understand the nuances of regulations, increasing the likelihood of errors.
• Neglecting to conduct thorough pre-submission reviews can lead to oversight. A lack of comprehensive checks often results in incomplete or inaccurate submissions.
• Overlooking stakeholder feedback during the submission process can hinder success. Engaging with internal and external experts ensures that submissions meet all necessary criteria.

Improvement Levers

Enhancing the Regulatory Submission Success Rate requires a proactive approach to compliance and quality assurance.

• Implement a centralized submission management system to streamline processes. This system can track deadlines, document requirements, and facilitate collaboration among teams.
• Conduct regular training sessions on regulatory updates and best practices. Keeping staff informed ensures that submissions are accurate and compliant with the latest standards.
• Establish a cross-functional review team to evaluate submissions before they are sent. Diverse perspectives can identify potential issues and enhance overall quality.
• Utilize analytics to identify trends in submission success and failure. Data-driven insights can inform process adjustments and improve future submissions.

KPI Depot is trusted by consulting, strategy, finance, and analytics teams at leading organizations worldwide, including those listed below.

OKRs That Use Regulatory Submission Success Rate

This KPI is written directly into the Medical Devices & Diagnostics KPI group's OKR material. The objective accelerate regulatory approval to reduce time-to-market without compromising compliance uses Regulatory Submission Success Rate as a first-pass key result sitting beside Time-to-Regulatory Approval, Regulatory Compliance Rate, and Regulatory Inspection Readiness. Its job in that objective is to be the quality counterweight: it proves that faster is not sloppier.

Framed as a key result, the directional goal is to raise the share of submissions accepted on first pass while approval time comes down, so gains in speed are earned through cleaner dossiers rather than more attempts. A team might set an illustrative first-pass target for the quarter, but the group's best-practice guidance to align key results with regulatory milestones argues for keeping this one directional and pairing it with Regulatory Audit Findings, so the same discipline that lifts submission success also shows up as fewer findings at inspection.

See OKR Examples for Medical Devices & Diagnostics

KPI Categories

This KPI is associated with the following categories and industries in our KPI database: